Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease

Published:2014-06-03 Issue:17 Volume:57 Page:7160-7181
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Benhamú Bellinda¹,Martín-Fontecha Mar¹,Vázquez-Villa Henar¹,Pardo Leonardo²,López-Rodríguez María L.¹

Affiliation:

1. Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain

2. Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm5003952

Reference199 articles.

1. Global Health and Aging (2011, publication by the National Institute on Aging and National Institutes of Health).http://www.who.int/ageing/publications/global_health.pdf(accessed May 14, 2014) .

2. Alzheimer’s Disease International: World Alzheimer Report 2013.http://www.alz.co.uk/research/WorldAlzheimerReport2013.pdf(accessed May 14, 2014) .

3. Medicines in Development. Alzheimer’s Disease (2013, report published by the Pharmaceutical Research and Manufacturers of America (PhRMA)).http://www.phrma.org/sites/default/files/Alzheimer%27s%202013.pdf(accessed May 14, 2014) .

4. Alzheimer's Disease

5. Pathways linking Aβ and tau pathologies

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways;Ageing Research Reviews;2024-02

2. Combinatorial therapy in Alzheimer's disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

3. 5-HT6 receptor antagonists. Design, synthesis, and structure–activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines;Bioorganic & Medicinal Chemistry Letters;2023-11

4. The challenges of finding novel and effective drugs targeting dementia and neuropsychiatric disturbances in PD: Insights from the SYNAPSE trial;Parkinsonism & Related Disorders;2023-09

5. Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interaction;Bioorganic & Medicinal Chemistry;2023-04